Researchers at the Clínic-IDIBAPS coordinated a study that highlights the efficacy of migraine treatment with a monoclonal antibody, galcanezumab, in1
The Committee for the Evaluation of Medicinal Products for Human Use of the Spanish Agency of Medicines and Medical Devices (AEMPS) has approved ARI01
A study published recently in the journal Clinical Cancer Research identified biomarkers that can predict the response to CAR T-cell therapy targetin1
A multicentre study led by the Hospital Clínic Barcelona-IDIBAPS demonstrates the efficacy of the CAR T-cell therapy ARI0002h in treating patients wi1
The researchers’ goal is to develop a method to reverse the exhaustion that affects T-cells during protracted battles with tumor cells, preventing th1
Immunotherapy has revolutionized the treatment of hepatocellular carcinoma. Researchers from the Hospital Clínic-IDIBAPS have published a review in t1
The Hospital Clínic Medical Oncology Service, led by Dr. Aleix Prat, has launched a home infusion programme for solid o1
The ACROPOLI clinical trial is being launched. It is a pioneering, nationwide research study that aims to assess the efficacy of immunotherapy in 291
An article published in the journal Nature suggests that immunotherapy is effective in patients with HCC of viral origin but does not increase surviv1
Hospital Clínic de Barcelona-IDIBAPS and Cellnex have today signed an agreement to launch a multicentre research project that will allow better under1
